KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Total Liabilities (2016 - 2025)

Rigel Pharmaceuticals has reported Total Liabilities over the past 16 years, most recently at $122.1 million for Q4 2025.

  • Quarterly results put Total Liabilities at $122.1 million for Q4 2025, down 24.01% from a year ago — trailing twelve months through Dec 2025 was $122.1 million (down 24.01% YoY), and the annual figure for FY2025 was $122.1 million, down 24.01%.
  • Total Liabilities for Q4 2025 was $122.1 million at Rigel Pharmaceuticals, down from $124.9 million in the prior quarter.
  • Over the last five years, Total Liabilities for RIGL hit a ceiling of $160.7 million in Q4 2024 and a floor of $122.1 million in Q4 2025.
  • Median Total Liabilities over the past 5 years was $143.7 million (2022), compared with a mean of $142.4 million.
  • Biggest five-year swings in Total Liabilities: surged 112.28% in 2021 and later dropped 24.01% in 2025.
  • Rigel Pharmaceuticals' Total Liabilities stood at $137.0 million in 2021, then increased by 7.99% to $147.9 million in 2022, then fell by 1.37% to $145.9 million in 2023, then rose by 10.16% to $160.7 million in 2024, then fell by 24.01% to $122.1 million in 2025.
  • The last three reported values for Total Liabilities were $122.1 million (Q4 2025), $124.9 million (Q3 2025), and $124.8 million (Q2 2025) per Business Quant data.